1 week ago
16
Millions of Americans have a blood test every year to measure LDL, often called "bad" cholesterol. But new research from Northwestern Medicine suggests that another test may do a better job of identifying who needs more aggressive treatment to reduce the risk of heart attacks and strokes.
The study, published in JAMA, found that measuring apolipoprotein B (apoB) was more effective than tracking LDL or non HDL cholesterol when deciding whether to inten...
English (US) ·